Aurobindo wins Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2017

Frankfurt, 24 October 2017 – Aurobindo Pharma Limited and Generics Bulletin are pleased to announce that Aurobindo has won the Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2017, organized by Generics Bulletin. The Company of the Year, Asia-Pacific Award was sponsored by Eva Pharma and judged by an expert panel. “Congratulations to Aurobindo for their win in what is a very competitive region for the industry,” commented Aidan Fry, Editor of Generics bulletin.

Now in their fourth year, the Awards were presented on Tuesday 24 October 2017 in Frankfurt, Germany, by Generics bulletin and co-hosts QuintilesIMS.

The Global Generics & Biosimilars Awards 2017 rewards ‘best practice’ in the two sectors, while at the same time encouraging improvements in every aspect of the way business is conducted. Every Award effectively underscores the efforts made by the global generics and biosimilars sectors to make more affordable medicines available to more people everywhere.